These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 34636415)

  • 1. An individual level infectious disease model in the presence of uncertainty from multiple, imperfect diagnostic tests.
    Ward C; Brown GD; Oleson JJ
    Biometrics; 2023 Mar; 79(1):426-436. PubMed ID: 34636415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A spatial epidemic model for disease spread over a heterogeneous spatial support.
    Porter AT; Oleson JJ
    Stat Med; 2016 Feb; 35(5):721-33. PubMed ID: 26365804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating Contact Network Uncertainty in Individual Level Models of Infectious Disease using Approximate Bayesian Computation.
    Almutiry W; Deardon R
    Int J Biostat; 2019 Dec; 16(1):. PubMed ID: 31812945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographically dependent individual-level models for infectious diseases transmission.
    Mahsin MD; Deardon R; Brown P
    Biostatistics; 2022 Jan; 23(1):1-17. PubMed ID: 32118253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A path-specific SEIR model for use with general latent and infectious time distributions.
    Porter AT; Oleson JJ
    Biometrics; 2013 Mar; 69(1):101-8. PubMed ID: 23323602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Goodness-of-fit measures for individual-level models of infectious disease in a Bayesian framework.
    Gardner A; Deardon R; Darlington G
    Spat Spatiotemporal Epidemiol; 2011 Dec; 2(4):273-81. PubMed ID: 22748225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian inference of hospital-acquired infectious diseases and control measures given imperfect surveillance data.
    Forrester ML; Pettitt AN; Gibson GJ
    Biostatistics; 2007 Apr; 8(2):383-401. PubMed ID: 16926230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hybrid stochastic model and its Bayesian identification for infectious disease screening in a university campus with application to massive COVID-19 screening at the University of Liège.
    Arnst M; Louppe G; Van Hulle R; Gillet L; Bureau F; Denoël V
    Math Biosci; 2022 May; 347():108805. PubMed ID: 35306009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The probability of failing in detecting an infectious disease at entry points into a country.
    Dell'Omodarme M; Prati MC
    Stat Med; 2005 Sep; 24(17):2669-79. PubMed ID: 15977301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birth/birth-death processes and their computable transition probabilities with biological applications.
    Ho LST; Xu J; Crawford FW; Minin VN; Suchard MA
    J Math Biol; 2018 Mar; 76(4):911-944. PubMed ID: 28741177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian meta-analysis of diagnostic tests allowing for imperfect reference standards.
    Menten J; Boelaert M; Lesaffre E
    Stat Med; 2013 Dec; 32(30):5398-413. PubMed ID: 24003003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Part 2. Development of Enhanced Statistical Methods for Assessing Health Effects Associated with an Unknown Number of Major Sources of Multiple Air Pollutants.
    Park ES; Symanski E; Han D; Spiegelman C
    Res Rep Health Eff Inst; 2015 Jun; (183 Pt 1-2):51-113. PubMed ID: 26333239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating infectious duration-dependent transmission into Bayesian epidemic models.
    Ward C; Brown GD; Oleson JJ
    Biom J; 2023 Mar; 65(3):e2100401. PubMed ID: 36285663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix models for childhood infections: a Bayesian approach with applications to rubella and mumps.
    Kanaan MN; Farrington CP
    Epidemiol Infect; 2005 Dec; 133(6):1009-21. PubMed ID: 16274497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stochastic Epidemic Models inference and diagnosis with Poisson Random Measure Data Augmentation.
    Nguyen-Van-Yen B; Del Moral P; Cazelles B
    Math Biosci; 2021 May; 335():108583. PubMed ID: 33713696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing parameter identifiability in compartmental dynamic models using a computational approach: application to infectious disease transmission models.
    Roosa K; Chowell G
    Theor Biol Med Model; 2019 Jan; 16(1):1. PubMed ID: 30642334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parameterizing Spatial Models of Infectious Disease Transmission that Incorporate Infection Time Uncertainty Using Sampling-Based Likelihood Approximations.
    Malik R; Deardon R; Kwong GP
    PLoS One; 2016; 11(1):e0146253. PubMed ID: 26731666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.